Suitability & Risks: For Qualified Biotechnology Investors

Suitability and risks are always a very important matter at InvestBio, and it should be for you too. If you understand and recognize what the risks and rewards are before investing you will be able to make better and more educated biotechnology investment decisions. All InvestBio investment products and services are serviced through DPEC Partners. In general, biotechnology investing is suitable for investors who:

Are experienced investors or have obtained the advice of an investment professional.
Are willing to accept the additional risks entailed in the volatile biotechnology sector.
Understand that stocks can, and likely will, have daily price fluctuations.
Recognize decisions made by the Food and Drug Administration (FDA) can effect or end a biotech's company's drug development program.
Are qualified accredited investors when considering investing in any venture capital opportunity, private placement or hedge fund.
Understand biotechnology investing involves a high degree of risk.

Biotechnology investing may not be suitable for all investors. This high degree of risk can work against you as well as for you. Before deciding to invest in the biotech sector you should carefully consider your investment objectives, level of experience, liquidity needs and amount of risk (risk tolerance) that you can comfortably accept. The possibility exists that you could sustain a substantial loss of some or all of your initial investment and therefore you should not invest money that you cannot afford to lose. Each prospectus or private placement memorandum that you receive addresses the risks inherent to each offering. You are strongly urged to read all of the material before committing to any investment. For questions regarding suitability and risks associated with biotechnology investing please contact *DPEC Partners * InvestBio does not offer any securities. InvestBio's biotechnology investment products and services can only be obtained through DPEC Capital, Inc.

	HOW TO INVEST
	SUITABILITY & RISKS
	ARE YOU AN ACCREDITED INVESTOR?

Market Capitalization, 1994-2005*: *Amounts are U.S. Dollars in billions.
Sources: Ernst & Young LLP and BioWorld